The India-based contract research organisation (CRO) commented that it is a complex domain and consequently chose to collaborate with Infosys on the adoption of the Microsoft software.
By installing Microsoft Dynamics NAV 2009, an enterprise resource planning (ERP) system, QSI has “streamlined and standardised” its business processes, according to Apurva Goswamy, the company’s CEO.
Goswamy added that this has helped QSI to improve its margins by identifying “where the slack is”, allowing the CRO to improve productivity, provide “seamless information flow” and file faster and more accurate reports.
Furthermore, the collaborators also installed Adrenalin to meet QSI’s human resource and payroll management needs. Adrenalin provides QSI with a platform to perform process standardisation, transaction processing, resource allocation and reduce manual effort.
QSI stated that it has a high manual dependence and believes the new software will help reduce this, in particular in its financial management, sales and marketing and resource planning.
Infosys added that Adrenalin has helped QSI to reduce invoice preparation time and improve data accuracy. By making these improvements QSI has increase revenues and productivity, according to a press statement.
QSI is a CRO focused on drug safety and offers single case processing, individual adverse event reports (ICSR) and related services, and grouped data processing, such as periodic safety update reports (PSUR).
The CRO was formed in 2004 and since then its scientific staff, including physicians, healthcare professionals and life scientists, have gained familiarity with hundreds of clinical studies and products from a drug safety perspective.